Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

[A long-term control of gastrointestinal stromal tumor with sunitinib].

Uno F, Fujiwara Y, Fujiwara T.

Gan To Kagaku Ryoho. 2013 Sep;40(9):1241-4. Japanese.

PMID:
24047789
[PubMed - indexed for MEDLINE]
2.

Surgical intervention for imatinib and sunitinib-resistant gastrointestinal stromal tumors.

Kikuchi H, Setoguchi T, Miyazaki S, Yamamoto M, Ohta M, Kamiya K, Sakaguchi T, Konno H.

Int J Clin Oncol. 2011 Dec;16(6):741-5. doi: 10.1007/s10147-011-0208-4. Epub 2011 Mar 12.

PMID:
21394667
[PubMed - indexed for MEDLINE]
3.

[A case of drug resistant recurrent gastrointestinal stromal tumor treated surgically by resection, partial hepatectomy and diaphragmectomy].

Ueda N, Morioka E, Kaida D, Tomita Y, Ohnishi T, Ohno Y, Noguchi M, Funaki H, Kinami S, Omote K, Nakano Y, Kosaka T, Nakata S, Minato H, Takamura H.

Gan To Kagaku Ryoho. 2012 Nov;39(12):2438-40. Japanese.

PMID:
23268103
[PubMed - indexed for MEDLINE]
4.

[A case of imatinib-resistant GIST treated by sunitinib].

Sakamoto Y, Akimoto H, Kojo M, Kawano H, Chinen Y, Morita K, Sugiyama M, Saeki H, Minami K, Soejima Y, Sakaguchi Y, Toh Y, Okamura T.

Gan To Kagaku Ryoho. 2011 May;38(5):827-30. Japanese.

PMID:
21566447
[PubMed - indexed for MEDLINE]
5.

Sunitinib malate for the treatment of metastatic renal cell carcinoma and gastrointestinal stromal tumors.

Adams VR, Leggas M.

Clin Ther. 2007 Jul;29(7):1338-53. Review.

PMID:
17825686
[PubMed - indexed for MEDLINE]
6.

Surgical debulking of gastrointestinal stromal tumors: is it a reasonable option after second-line treatment with sunitinib?

Pantaleo MA, Di Battista M, Catena F, Astorino M, Saponara M, Di Scioscio V, Santini D, Piazzi G, Castellucci P, Brandi G, Biasco G.

J Cancer Res Clin Oncol. 2008 May;134(5):625-30. doi: 10.1007/s00432-007-0347-1. Epub 2008 Jan 17.

PMID:
18202855
[PubMed - indexed for MEDLINE]
7.

Surgical resection of residual disease in initially inoperable imatinib-resistant/intolerant gastrointestinal stromal tumor treated with sunitinib.

Ruka W, Rutkowski P, Szawłowski A, Nowecki Z, Debiec-Rychter M, Grzesiakowska U, Dziewirski W, Siedlecki JA, Michej W.

Eur J Surg Oncol. 2009 Jan;35(1):87-91. doi: 10.1016/j.ejso.2008.01.003. Epub 2008 Mar 4.

PMID:
18289826
[PubMed - indexed for MEDLINE]
8.

[A case of hepatectomy for gastrointestinal stromal tumor with multiple liver metastasis after size reduction in a Jehovah's Witness patient].

Kikutake T, Kawamoto S, Yoshida T.

Gan To Kagaku Ryoho. 2012 Nov;39(12):2015-7. Japanese.

PMID:
23267961
[PubMed - indexed for MEDLINE]
9.

The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study.

Rutkowski P, Bylina E, Klimczak A, Switaj T, Falkowski S, Kroc J, Lugowska I, Brzeskwiniewicz M, Melerowicz W, Osuch C, Mierzejewska E, Wasielewski K, Woźniak A, Grzesiakowska U, Nowecki ZI, Siedlecki JA, Limon J.

BMC Cancer. 2012 Mar 22;12:107. doi: 10.1186/1471-2407-12-107.

PMID:
22439647
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial.

Demetri GD, van Oosterom AT, Garrett CR, Blackstein ME, Shah MH, Verweij J, McArthur G, Judson IR, Heinrich MC, Morgan JA, Desai J, Fletcher CD, George S, Bello CL, Huang X, Baum CM, Casali PG.

Lancet. 2006 Oct 14;368(9544):1329-38.

PMID:
17046465
[PubMed - indexed for MEDLINE]
11.

Effect of sunitinib on metastatic gastrointestinal stromal tumor in patients with neurofibromatosis type 1: a case report.

Kalender M, Sevinc A, Tutar E, Sirikci A, Camci C.

World J Gastroenterol. 2007 May 14;13(18):2629-32.

PMID:
17552016
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Sunitinib-induced hyperammonemic encephalopathy in gastrointestinal stromal tumors.

Lee NR, Yhim HY, Yim CY, Kwak JY, Song EK.

Ann Pharmacother. 2011 Oct;45(10):e56. doi: 10.1345/aph.1Q038. Epub 2011 Sep 27.

PMID:
21954449
[PubMed - indexed for MEDLINE]
13.

Sunitinib-resistant gastrointestinal stromal tumors harbor cis-mutations in the activation loop of the KIT gene.

Nishida T, Takahashi T, Nishitani A, Doi T, Shirao K, Komatsu Y, Nakajima K, Hirota S; Japanese Study Group on GIST.

Int J Clin Oncol. 2009 Apr;14(2):143-9. doi: 10.1007/s10147-008-0822-y. Epub 2009 Apr 24.

PMID:
19390946
[PubMed - indexed for MEDLINE]
14.

Late hepatic metastasis in the evolution of gastrointestinal stromal tumors.

Tivadar B, Serban B, Mircea M, Tivadar B Jr, Leonard A, Daniela P, Simona M.

Hepatogastroenterology. 2010 Jan-Feb;57(97):95-7.

PMID:
20422880
[PubMed - indexed for MEDLINE]
15.

Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib.

Janeway KA, Albritton KH, Van Den Abbeele AD, D'Amato GZ, Pedrazzoli P, Siena S, Picus J, Butrynski JE, Schlemmer M, Heinrich MC, Demetri GD.

Pediatr Blood Cancer. 2009 Jul;52(7):767-71. doi: 10.1002/pbc.21909.

PMID:
19326424
[PubMed - indexed for MEDLINE]
16.

Recent advances in therapy for gastrointestinal stromal tumors.

Maki RG.

Curr Oncol Rep. 2007 May;9(3):165-9. Review.

PMID:
17430686
[PubMed - indexed for MEDLINE]
17.

Sunitinib for imatinib-resistant GIST.

Joensuu H.

Lancet. 2006 Oct 14;368(9544):1303-4. No abstract available.

PMID:
17046443
[PubMed - indexed for MEDLINE]
18.

[A successfully resected case of liver metastasis of gastrointestinal stromal tumor responding to neoadjuvant chemotherapy with imatinib mesylate and interventional radiology].

Tamura J, Nakayama Y, Kitaguchi K, Ura K, Taira K, Ooe H, Yoshikawa A, Ishigami S, Baba N.

Gan To Kagaku Ryoho. 2009 Oct;36(10):1769-72. Japanese.

PMID:
19838046
[PubMed - indexed for MEDLINE]
19.

Approval summary: sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma.

Goodman VL, Rock EP, Dagher R, Ramchandani RP, Abraham S, Gobburu JV, Booth BP, Verbois SL, Morse DE, Liang CY, Chidambaram N, Jiang JX, Tang S, Mahjoob K, Justice R, Pazdur R.

Clin Cancer Res. 2007 Mar 1;13(5):1367-73. Review.

PMID:
17332278
[PubMed - indexed for MEDLINE]
Free Article
20.

Cost-effectiveness analysis of sunitinib in patients with metastatic and/or unresectable gastrointestinal stroma tumours (GIST) after progression or intolerance with imatinib.

Paz-Ares L, García del Muro X, Grande E, González P, Brosa M, Díaz S.

Clin Transl Oncol. 2008 Dec;10(12):831-9.

PMID:
19068454
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk